In the first six months of 2023, approximately 6 million prescriptions were written for the class of drugs that include Wagovi and Ozempic. These medications assist in insulin production and signal the brain to reduce appetite. However, with the festive season upon us, some individuals using weight loss drugs are contemplating skipping their doses. To shed light on this matter, we turn to Dr. Lena Wynn, an esteemed expert in the field.
Dr. Wynn emphasizes the potential side effects associated with these drugs, such as nausea, vomiting, diarrhea, constipation, and stomach pain. Understandably, these symptoms may not align well with the enjoyment of Christmas, vacations, or other celebratory occasions. However, Dr. Wynn urges patients to view obesity as a chronic condition and weight loss drugs as similar to medications for high blood pressure, diabetes, or heart disease. Just as it's important not to stop those medications without consulting a doctor, the same holds true for semaglutide, including Wagovi and Ozempic. Seeking individualized advice from a healthcare professional is crucial in making informed decisions.
